Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Prognostic factors of acute partial transverse myelitis-reply.
Response to comment on "dimethyl fumarate (tecfidera): a new oral agent for multiple sclerosis".
High interindividual variability in the CD4/CD8 T cell ratio and natalizumab concentration levels in the cerebrospinal fluid of patients with multiple sclerosis.
Differential effects of fingolimod (FTY720) on immune cells in the CSF and blood of patients with MS.
Multiple sclerosis and pregnancy: a single-centre prospective comparative study.
[Current therapy of multiple sclerosis].
Coping Among Individuals With Multiple Sclerosis: Evaluating a Goodness-of-Fit Model.
Inflammasomes and human autoimmunity: A comprehensive review.
Serum and cerebrospinal fluid concentrations of homoarginine, arginine, asymmetric and symmetric dimethylarginine, nitrite and nitrate in patients with multiple sclerosis and neuromyelitis optica.
Visual pathway abnormalities were found in most multiple sclerosis patients despite history of previous optic neuritis.
Natalizumab-Induced Progressive Multifocal Leukoencephalopathy.
Trigeminal neuralgia: A new therapy?
Optic and auditory pathway dysfunction in demyelinating neuropathies.
Th17 cells in central nervous system autoimmunity.
Pathologic laughing as a presenting feature in a patient with neuromyelitis optica.
Relations of low contrast visual acuity, quality of life and multiple sclerosis functional composite: a cross-sectional analysis.
Human Herpesvirus 6A infection in CD46 transgenic mice: viral persistence in the brain and increased production of proinflammatory chemokines via TLR9.
N-acetylcysteine (NAC) in neurological disorders: mechanisms of action and therapeutic opportunities.
Multiple sclerosis: Could simvastatin slow down secondary progressive MS?
A case of neuromyelitis optica spectrum disorder presenting with severe orthostatic hypotension.
Retinal hemorrhages following fingolimod treatment for multiple sclerosis; a case report.
Intrathecal CD4(+) and CD8(+) T cell responses to endogenously synthesized candidate disease-associated human autoantigens in multiple sclerosis patients.
Cytokine-producing B cells: a translational view on their roles in human and mouse autoimmune diseases.
A case of acute disseminated encephalomyelitis disguised as mania in a woman with known bipolar disorder.
2-Methoxyestradiol inhibits proliferation and induces apoptosis independently of estrogen receptors alpha and beta.
Pages
« first
‹ previous
…
438
439
440
441
442
443
444
445
446
…
next ›
last »